Greenwich Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Greenwich Lifesciences in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
2.088.7015.32
Details
Intrinsic
Valuation
LowReal ValueHigh
8.0626.1332.75
Details
Naive
Forecast
LowNext ValueHigh
2.769.3816.00
Details
1 Analysts
Consensus
LowTarget PriceHigh
78.0078.0078.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Greenwich Lifesciences. Your research has to be compared to or analyzed against Greenwich Lifesciences' peers to derive any actionable benefits. When done correctly, Greenwich Lifesciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Greenwich Lifesciences.

Greenwich Lifesciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Greenwich Lifesciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Greenwich and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Greenwich Lifesciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Greenwich Lifesciences Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Greenwich Lifesciences stock performing well and Greenwich Lifesciences company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Greenwich Lifesciences' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 2.83  0.13  0.06  0.04  3.51  0.0458 (3.05)  5.66 (5.40)  36.79 
MSFT 1.92  0.00  0.00 (0.19)  0.00 (0.0322)  0.00  2.97 (4.24)  9.36 
UBER 3.40 (0.36)  0.00 (0.39)  0.00 (0.13)  0.00  6.55 (7.19)  18.56 
F 2.47 (0.25)  0.00 (0.35)  0.00 (0.12)  0.00  3.89 (5.54)  16.83 
T 1.29  0.38  0.27  0.39  1.38  0.25 (1.47)  2.99 (2.47)  12.17 
A 2.00  0.06  0.00 (0.14)  0.00  0.0065  0.00  3.19 (3.50)  9.77 
CRM 2.66 (0.02)  0.00 (0.20)  0.00 (0.0477)  0.00  6.33 (5.28)  16.84 
JPM 1.45 (0.12)  0.00 (0.31)  0.00 (0.07)  0.00  2.98 (3.00)  10.78 
MRK 1.07  0.28  0.33  0.38  0.99  0.27 (1.23)  2.16 (1.65)  7.61 
XOM 1.94  0.26  0.09  0.10  2.91  0.11 (1.70)  3.03 (3.96)  11.86 

Cross Equities Net Income Analysis

Compare Greenwich Lifesciences and related stocks such as 3M Company Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
MMM4.3 B4.3 B4.4 B4.7 BB4.8 BB4.9 B5.3 B4.5 B5.4 B5.9 BB

Greenwich Lifesciences and related stocks such as 3M Company Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Greenwich Lifesciences financial statement analysis. It represents the amount of money remaining after all of Greenwich Lifesciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Greenwich Lifesciences Competitive Analysis

The better you understand Greenwich Lifesciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Greenwich Lifesciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Greenwich Lifesciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
GLSI
MMM
 5.79 
 8.96 
 0.71 
 128.49 
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Current Valuation
Cash Flow from Operations
Operating Margin
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Market Capitalization
Price to Sales
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Greenwich Lifesciences Competition Performance Charts

Complement your Greenwich Lifesciences position

In addition to having Greenwich Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Providers Thematic Idea Now

Insurance Providers
Insurance Providers Theme
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 30 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
View All  Next Launch Insurance Providers
Please check Greenwich Lifesciences Correlation with its peers. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Greenwich Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
110.9 M
Return On Assets
-0.15
Return On Equity
-0.24
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
GLSI
 Stock
  

USD 8.96  0.49  5.79%   

Greenwich Lifesciences competes with 3M; as well as few others. The company conducts business under Healthcare sector and is part of Biotechnology industry. Analyzing Greenwich Lifesciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Greenwich Lifesciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Greenwich Lifesciences competition on your existing holdings. Please check Greenwich Lifesciences Correlation with its peers.
  
Refresh
The current Return on Average Assets is estimated to decrease to -0.17. The current Return on Invested Capital is estimated to decrease to 7.81. Greenwich Lifesciences Assets Non Current are most likely to decrease significantly in the upcoming years. The last year's value of Assets Non Current was reported at 17,852.4. The current Goodwill and Intangible Assets is estimated to increase to about 14.2 K, while Total Assets are projected to decrease to roughly 22.4 M.